000697027 000__ 02713cam\a2200457Ki\4500 000697027 001__ 697027 000697027 005__ 20230306135633.0 000697027 006__ m\\\\\o\\d\\\\\\\\ 000697027 007__ cr\cnu---unuuu 000697027 008__ 140228s2014\\\\gw\a\\\\ob\\\\000\0\eng\d 000697027 0167_ $$a016636216$$2Uk 000697027 019__ $$a871174532 000697027 020__ $$a9783642395901 $$qelectronic book 000697027 020__ $$a3642395902 $$qelectronic book 000697027 020__ $$z9783642395895 000697027 0247_ $$a10.1007/978-3-642-39590-1$$2doi 000697027 035__ $$aSP(OCoLC)ocn871206684 000697027 035__ $$aSP(OCoLC)871206684$$z(OCoLC)871174532 000697027 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dGW5XE$$dUKMGB$$dYDXCP$$dCOO$$dIDEBK$$dE7B 000697027 049__ $$aISEA 000697027 050_4 $$aRC280.L9 000697027 08204 $$a616.99446$$223 000697027 24500 $$aRare lymphomas$$h[electronic resource] /$$cMartin Dreyling, Michael E. Williams, editors. 000697027 264_1 $$aHeidelberg :$$bSpringer,$$c[2014]. 000697027 264_4 $$c©2014. 000697027 300__ $$a1 online resource ;$$billustrations. 000697027 336__ $$atext$$btxt$$2rdacontent 000697027 337__ $$acomputer$$bc$$2rdamedia 000697027 338__ $$aonline resource$$bcr$$2rdacarrier 000697027 4901_ $$aHematologic malignancies 000697027 504__ $$aIncludes bibliographical references. 000697027 506__ $$aAccess limited to authorized users. 000697027 520__ $$aThe past decade has witnessed tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma as well as in understanding of the underlying molecular pathogenesis. Optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors. Even more importantly, molecular targeted approaches have been shown to be effective in the treatment of distinct lymphoma subtypes. Against this background, clinical management of especially the rare lymphomas remains a challenge for the general oncologist. This book provides a comprehensive overview of current treatment strategies in these rare lymphoma subtypes. Experts in the field from around the world describe the histomorphology in a clinically relevant manner, consider the role of risk factors in detail, and discuss the spectrum of therapeutic approaches. Special emphasis is placed on the translation of molecular science into clinical care, and a disease-specific algorithm is proposed for each entity. This book will prove an excellent resource for both experienced and inexperienced practitioners. 000697027 650_0 $$aLymphomas. 000697027 7001_ $$aDreyling, Martin,$$eeditor of compilation. 000697027 7001_ $$aWilliams, Michael E.,$$eeditor of compilation. 000697027 830_0 $$aHematologic malignancies (Series) 000697027 85280 $$bebk$$hSpringerLink 000697027 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://dx.doi.org/10.1007/978-3-642-39590-1$$zOnline Access 000697027 909CO $$ooai:library.usi.edu:697027$$pGLOBAL_SET 000697027 980__ $$aEBOOK 000697027 980__ $$aBIB 000697027 982__ $$aEbook 000697027 983__ $$aOnline 000697027 994__ $$a92$$bISE